HIFS:NASDAQHingham Institution for Savings Analysis
Data as of 2026-06-18 - not real-time
$282.24
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Hingham Institution for Savings (HIFS) is trading at $282.24, notably below its 20‑day ($286.15) and 50‑day ($286.18) simple moving averages, signaling a short‑term bearish bias despite a bullish MACD crossover (MACD line $1.72 vs signal $1.68). Valuation metrics are attractive: a trailing P/E of 12.37 is well under the industry average of 17.05 and the price‑to‑book of 1.28 suggests the stock is undervalued relative to peers. However, the company faces material headwinds – revenue has contracted 30.5%, debt sits at $1.41 B with minimal cash reserves, and recent news flags rising non‑accrual loans, weak net interest margins, and elevated commercial‑real‑estate exposure, all of which amplify risk.
The technical picture is mixed: volatility is high at 31% over 30 days and beta exceeds 1, indicating sensitivity to market swings, while volume is trending upward, hinting at accumulating interest near the support level of $266.58. Strong profitability (profit margin 51.6% and ROE ~11%) provides a cushion, but the lack of dividend and uncertain earnings outlook (forward EPS unavailable) temper enthusiasm. Investors should weigh the attractive valuation against the pronounced asset‑quality concerns and leverage profile before positioning.
The technical picture is mixed: volatility is high at 31% over 30 days and beta exceeds 1, indicating sensitivity to market swings, while volume is trending upward, hinting at accumulating interest near the support level of $266.58. Strong profitability (profit margin 51.6% and ROE ~11%) provides a cushion, but the lack of dividend and uncertain earnings outlook (forward EPS unavailable) temper enthusiasm. Investors should weigh the attractive valuation against the pronounced asset‑quality concerns and leverage profile before positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term SMAs indicating bearish momentum
- Asset‑quality concerns and high debt increase downside risk
- Increasing volume suggests potential bottoming near support
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Attractive valuation relative to industry peers
- Strong profit margins and ROE provide earnings resilience
- Technical bullish MACD and rising volume may support a rebound
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent CRE and non‑accrual loan exposure limit upside
- High leverage and limited cash buffer heighten structural risk
- Value orientation may sustain price stability if fundamentals improve
Key Metrics & Analysis
Financial Health
Revenue Growth-30.50%
Profit Margin51.56%
P/E Ratio12.4
ROE10.93%
ROA1.11%
P/B Ratio1.3
Op. Cash Flow$37.4M
Industry P/E17.1
Technical Analysis
TrendBearish
RSI47.2
Support$266.58
Resistance$300.99
MA 20$286.15
MA 50$286.18
MA 200$286.88
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta1.16
Volatility31.26%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.